Clinical Trial Update: A Retrospective Study to Evaluate the Effectiveness of onabotulinumtoxinA in Preventing Headaches in Patients With Chronic Migraines

View source ↗

Summary

This clinical trial update shows that the retrospective study evaluating onabotulinumtoxinA for preventing headaches in chronic migraine patients has been withd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• OnabotulinumtoxinA (botulinum toxin type A)

Snippet

Sponsor: Allergan | Conditions: Chronic Migraine, Headache | Status: WITHDRAWN